Chest radiography as a predictor of outcome in posttransplantation lymphoproliferative disorder in lung allograft recipients

American Journal of Roentgenology

Volumn 171, Issue 2, 1998, Pages 375-382

  Pickhardt, Perry J ^a   Siegel, Marilyn J ^a   Anderson, D Claire ^a   Hayashi, Robert ^b   Debaun, Michael R ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 0031819981     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.171.2.9694455     Document Type: Article

References (16)

1. Penn I, Hammond W, Brettschneider L, Starzl TE. Malignant lymphomas in transplantation patients. Transplant Proc 1969;1:106-112
2. Nalesnik MA. Posttransplantation lymphoproliferative disorders (lymphoproliferative disease): current perspectives. Semin Thorac Cardiovasc Surg 1996;8:139-148
3. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988; 133:173-192
4. Nalesnik MA, Makowka L, Starzl TE. The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr Probl Surg 1988;25: 367-472
5. Armitage JM, Kormos RL, Stuart RS. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant 1991;10:877-887
6. Montone KT, Litzky LA, Wurster A, et al. Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation. Surgery 1996;119:544-551
7. Yousem SA, Parmjeet R, Locker J, et al. Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft. Hum Pathol 1989;20:361-369
8. Starzl TE, Nalesnik MA, Porter KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet 1984;1:583-587
9. Swerdlow SH. Classification of the posttransplant lymphoproliferative disorders: from the past to the present. Semin Diagn Pathol 1997;14:2-7
10. Ho M, Jaffe R, Miller G, et al. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 1988;45:719-727
11. Boyle GJ, Michaels MG, Webber SA, et al. Posttransplantation lymphoproliferative disorders in pediatric thoracic organ recipients. J Pediatr 1997; 131:309-313
12. Dodd GD, Ledesma-Medina J, Baron RL, Fuhrman CR. Posttransplant lymphoproliferative disorder: intrathoracic manifestations. Radiology 1992;184: 65-69
13. Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology 1985;157:611-614
14. Shreeniwas R, Schulman LL, Berkmen YM, McGregor CC, Austin JHM. Opportunistic bronchopulmonary infections after lung transplantation: clinical and radiographic findings. Radiology 1996; 200:349-356
15. Penn I. Immunosuppression: a contributing factor in lymphoma formation. Clin Transplant 1992; 6:214-219
16. Benkerrou M, Durandy A, Fischer A. Therapy for transplant-related lymphoproliferative diseases. Hematol Oncol Clin North Am 1993;7:467-475